Method for Measuring Postantifungal Effect inAspergillusSpecies
Open Access
- 1 June 2002
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (6), 1960-1965
- https://doi.org/10.1128/aac.46.6.1960-1965.2002
Abstract
An in vitro method for determination of postantifungal effect (PAFE) in molds was developed by using three isolates each of Aspergillus fumigatus, A. flavus, A. terreus, A. nidulans, and A. ustus. MICs of amphotericin B and itraconazole were determined by using National Committee for Clinical Laboratory Standards guidelines (M38-P). The inoculum was prepared in RPMI 1640 broth buffered with MOPS (morpholinepropanesulfonic acid) at pH 7.0, and conidia were exposed to amphotericin B and itraconazole at concentrations of 4, 1, and 0.25 times the MIC, each for 4, 2, and 1 h at 37°C. The same procedure was followed for controls with drug-free medium. Following exposure, the conidia were washed three times in saline and the numbers of CFU per milliliter were determined. Exposed and control conidia were then inoculated into microtitration plates and incubated at 37°C for 48 h in a spectrophotometer reader. The optical density (OD) was measured automatically at 10-min intervals, resulting in growth curves. PAFE was quantified by comparing three arbitrary points in the control growth curve, the first increase of OD and the points when 20 and 50% of the maximal growth were reached, with the growth curve of drug-exposed conidia. Amphotericin B induced PAFE in A. fumigatus at four times the MIC after 2 and 4 h of exposure ranging from 1.83 to 6.00 h and 9.33 to 10.80 h, respectively. Significantly shorter PAFEs or lack of PAFE was observed for A. terreus, A. ustus, and A. nidulans. Itraconazole did not induce measurable PAFE in the Aspergillus isolates at any concentration or exposure time tested. Further studies are warranted to investigate the implications of PAFE in relation to clinical efficacy and dosing frequency.Keywords
This publication has 24 references indexed in Scilit:
- Pharmacodynamics of Amphotericin B in a Neutropenic-Mouse Disseminated-Candidiasis ModelAntimicrobial Agents and Chemotherapy, 2001
- Analysis of Growth Characteristics of Filamentous Fungi in Different Nutrient MediaJournal of Clinical Microbiology, 2001
- Postantifungal Effects of Echinocandin, Azole, and Polyene Antifungal Agents against Candida albicans and Cryptococcus neoformansAntimicrobial Agents and Chemotherapy, 2000
- Influence of pH and Concentration on the Postantifungal Effect and on the Effects of Sub-MIC Concentrations of 4 Antifungal Agents on Previously Treated Candida spp.Scandinavian Journal of Infectious Diseases, 2000
- Pulmonary Aspergillosis and Invasive Disease in AIDSChest, 1998
- Activity of fluconazole: postantifungal effect, effects of low concentrations and of pretreatment on the susceptibility of Candida albicans to leucocytesJournal of Antimicrobial Chemotherapy, 1994
- Administering amphotericin B—a practical approachJournal of Antimicrobial Chemotherapy, 1994
- The postantibiotic effect of antifungal agents against common pathogenic yeastsJournal of Antimicrobial Chemotherapy, 1994
- Turbidometric characterization of the postantifungal effect: comparative studies with amphotericin B, 5‐fluorocytosine and miconazole on Candida albicansMycoses, 1991
- Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholateAntimicrobial Agents and Chemotherapy, 1989